Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interventions and therapeutic evaluation for coal workers' pneumoconiosis
ChiCTR2100050555Phase 4Recruiting
- Sponsor
- First Affiliated Hospital of Shanxi Medical University
- Start
- Oct 2021
- Modality
- Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of pirfenidone, tetrandrine and bromhexine in coal workers' pneumoconiosis (CWP) (5 arms), sponsored by First Affiliated Hospital of Shanxi Medical University. Primary endpoint: Pulmonary function test. Started Oct 2021; status: recruiting.
02
Drugs
pirfenidonetetrandrinebromhexine
03
Conditions
coal workers' pneumoconiosis (CWP)
Beyond the preview
Go deeper on ChiCTR2100050555.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100050555.